Aaron Barchowsky

Dr. Aaron Barchowsky


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2008 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
Adam C. StraubAdam C. Straub
Adam C. Straub
KCKatherine A. Clark
Katherine A. Clark
MRMark A. Ross
Mark A. Ross
ACAshwin G. Chandra
Ashwin G. Chandra
SLSong Li
Song Li
ABAaron Barchowsky
Aaron Barchowsky
Environmental arsenic exposure, through drinking contaminated water, is a significant risk factor for developing vascular diseases and is associated with liver portal hypertension, vascular shunting, and portal fibrosis through unknown mechanisms. We found that the addition of low doses of arsenite to the drinking water of mice resulted in marked pathologic remodeling in liver sinusoidal endothelial cells (SECs), including SEC defenestration, capillarization, increased junctional PECAM-1 expression, protein nitration, and decreased liver clearance of modified albumin. Furthermore, the pathologic changes observed after in vivo exposure were recapitulated in isolated mouse SECs exposed to arsenic in culture. To investigate the role of NADPH oxidase–generated ROS in this remodeling, we examined the effect of arsenite in the drinking water of mice deficient for the p47 subunit of the NADPH oxidase and found that knockout mice were protected from arsenite-induced capillarization and protein nitration. Furthermore, ex vivo arsenic exposure increased SEC superoxide generation, and this effect was inhibited by addition of a Nox2 inhibitor and quenched by the cell-permeant superoxide scavenger. In addition, inhibiting either oxidant generation or Rac1-GTPase blocked ex vivo arsenic-stimulated SEC differentiation and dysfunction. Our data indicate that a Nox2-based oxidase is required for SEC capillarization and that it may play a central role in vessel remodeling following environmentally relevant arsenic exposures.

1 July 2014 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
PDF file
SOShilpi Oberoi
Shilpi Oberoi
ABAaron Barchowsky
Aaron Barchowsky
FWFelicia Wu
Felicia Wu
Background: Arsenic is a ubiquitous, naturally occurring metalloid that poses a significant human cancer risk. While water consumption provides the majority of human exposure, millions of individuals worldwide are significantly exposed to arsenic through naturally occurring levels of arsenic in grains, vegetables, meats and fish, as well as through food processed with water containing arsenic. Thus, we estimated the global burdens of disease for bladder, lung, and skin cancers attributable to inorganic arsenic in food. Methods: To determine foodborne inorganic arsenic exposures worldwide, we used World Health Organization estimates of food consumption in thirteen country clusters, in conjunction with reported measurements of total and inorganic arsenic in different foods. We estimated slope factors for arsenic-related bladder and lung cancers, and used the U.S. Environmental Protection Agency skin cancer slope factor, to calculate the annual risk of the cancer incidence in males and females within each country cluster. Results: We estimated that each year 9,129 to 119,176 additional cases of bladder cancer, 11,844 to 121,442 of lung cancer, and 10,729 to 110,015 of skin cancer worldwide are attributable to inorganic arsenic in food. Conclusions: These estimates indicate that foodborne arsenic exposure causes a significant global burden of human disease. Impact: Estimating the global cancer burden caused by arsenic exposure in food will support policies that reduce exposure to disease-promoting environmental hazards. Cancer Epidemiol Biomarkers Prev; 23(7); 1187–94. ©2014 AACR.

1 July 2019 in Environmental Research
Verified
Journal Article
Closed access
HGHerman J. Gibb
Herman J. Gibb
ABAaron Barchowsky
Aaron Barchowsky
DBDavid Bellinger
David Bellinger
PBP. Michael Bolger
P. Michael Bolger
CCClark Carrington
Clark Carrington
BDBrecht Devleesschauwer
Brecht Devleesschauwer

22 December 2006 in Hepatology
Verified
Journal Article
Open access
PDF file
Adam C. StraubAdam C. Straub
Adam C. Straub
DSDonna B. Stolz
Donna B. Stolz
MRMark A. Ross
Mark A. Ross
AHAraceli Hernández-Zavala
Araceli Hernández-Zavala
NSNicole V. Soucy
Nicole V. Soucy
ABAaron Barchowsky
Aaron Barchowsky
Trivalent arsenic [As(III)] is a well-known environmental toxicant that causes a wide range of organ-specific diseases and cancers. In the human liver, As(III) promotes vascular remodeling, portal fibrosis, and hypertension, but the pathogenesis of these As(III)-induced vascular changes is unknown. To investigate the hypothesis that As(III) targets the hepatic endothelium to initiate pathogenic change, mice were exposed to 0 or 250 parts per billion (ppb) of As(III) in their drinking water for 5 weeks. Arsenic(III) exposure did not affect the overall health of the animals, the general structure of the liver, or hepatocyte morphology. There was no change in the total tissue arsenic levels, indicating that arsenic does not accumulate in the liver at this level of exposure. However, there was significant vascular remodeling with increased sinusoidal endothelial cell (SEC) capillarization, vascularization of the peribiliary vascular plexus (PBVP), and constriction of hepatic arterioles in As(III)-exposed mice. In addition to ultrastructural demonstration of SEC defenestration and capillarization, quantitative immunofluorescence analysis revealed increased sinusoidal PECAM-1 and laminin-1 protein expression, suggesting gain of adherens junctions and a basement membrane. Conversion of SECs to a capillarized, dedifferentiated endothelium was confirmed at the cellular level with demonstration of increased caveolin-1 expression and SEC caveolae, as well as increased membrane-bound Rac1-GTPase. Conclusion : These data demonstrate that exposure to As(III) causes functional changes in SEC signaling for sinusoidal capillarization that may be initial events in pathogenic changes in the liver. (Hepatology 2007; 45:205–212.)

1 December 2015 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
RDRishu Dheer
Rishu Dheer
JPJena Patterson
Jena Patterson
MDMark Dudash
Mark Dudash
ESElyse N. Stachler
Elyse N. Stachler
KBKyle Bibby
Kyle Bibby
JSJohn F. Stolz
John F. Stolz

1 February 2015 in Environmental Pollution
Verified
Journal Article
Closed access
AMAngela M. Malek
Angela M. Malek
ABAaron Barchowsky
Aaron Barchowsky
RBRobert Bowser
Robert Bowser
THTerry Heiman-Patterson
Terry Heiman-Patterson
DLDavid Lacomis
David Lacomis
Evelyn TalbottEvelyn Talbott
Evelyn Talbott